Arcadia Biosciences, Inc. (RKDA)
0.1648
-0.04
(-19.02%)
USD |
NASDAQ |
Oct 16, 16:00
0.1594
-0.01
(-3.28%)
After-Hours: 20:00
Arcadia Biosciences Gross Profit Margin (Quarterly) : 43.73% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.73% |
| March 31, 2026 | 36.36% |
| December 31, 2025 | 21.31% |
| September 30, 2025 | 32.10% |
| June 30, 2025 | 43.37% |
| March 31, 2025 | 43.17% |
| December 31, 2024 | 31.99% |
| September 30, 2024 | 32.86% |
| June 30, 2024 | 51.53% |
| March 31, 2024 | 52.28% |
| December 31, 2023 | 62.81% |
| September 30, 2023 | 36.98% |
| June 30, 2023 | 49.88% |
| March 31, 2023 | 44.16% |
| December 31, 2022 | -20.97% |
| September 30, 2022 | 28.15% |
| June 30, 2022 | 10.65% |
| March 31, 2022 | -7.39% |
| December 31, 2021 | -72.92% |
| September 30, 2021 | -5.68% |
| June 30, 2021 | -12.95% |
| March 31, 2021 | -3.38% |
| December 31, 2020 | 75.65% |
| September 30, 2020 | -486.3% |
| Date | Value |
|---|---|
| June 30, 2020 | -430.2% |
| March 31, 2020 | 45.31% |
| December 31, 2019 | -34.86% |
| September 30, 2019 | -5.87% |
| June 30, 2019 | -51.72% |
| March 31, 2019 | -67.72% |
| December 31, 2018 | 48.20% |
| September 30, 2018 | 66.49% |
| June 30, 2018 | 37.84% |
| March 31, 2018 | 83.18% |
| December 31, 2017 | 98.53% |
| September 30, 2017 | 93.21% |
| June 30, 2017 | 88.29% |
| March 31, 2017 | 89.59% |
| December 31, 2016 | -20.93% |
| September 30, 2016 | 90.70% |
| June 30, 2016 | 84.05% |
| March 31, 2016 | 82.75% |
| December 31, 2015 | 50.30% |
| September 30, 2015 | 94.76% |
| June 30, 2015 | 92.59% |
| March 31, 2015 | 88.71% |
| December 31, 2014 | 96.14% |
| December 31, 2013 | 90.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -- |
| PMGC Holdings, Inc. | 8.00% |
| Archer-Daniels-Midland Co. | 6.27% |
| Alico, Inc. | 44.76% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -315.6% |
| Return on Assets | -163.0% |
| Return on Invested Capital | -315.4% |
| Profit Margin (Quarterly) | -434.2% |
| Operating Margin (Quarterly) | -34.37% |
| Return on Net Operating Assets | -446.6% |